Hospira Company Profile
✉ Email this page to a colleague
What is the competitive landscape for HOSPIRA, and when can generic versions of HOSPIRA drugs launch?
HOSPIRA has five hundred and eighteen approved drugs.
There are nine US patents protecting HOSPIRA drugs. There are seven tentative approvals on HOSPIRA drugs.
There are sixty-nine patent family members on HOSPIRA drugs in thirty-eight countries and four hundred and nineteen supplementary protection certificates in sixteen countries.
Summary for Hospira
| International Patents: | 69 |
| US Patents: | 9 |
| Tradenames: | 333 |
| Ingredients: | 210 |
| NDAs: | 518 |
| Patent Litigation for Hospira: | See patent lawsuits for Hospira |
| PTAB Cases with Hospira as petitioner: | See PTAB cases with Hospira as petitioner |
Drugs and US Patents for Hospira
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Hospira | ADENOSINE | adenosine | SOLUTION;INTRAVENOUS | 203883-001 | Mar 24, 2014 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
| Hospira | MITOMYCIN | mitomycin | INJECTABLE;INJECTION | 064106-001 | Nov 29, 1995 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
| Hospira | CIMETIDINE HYDROCHLORIDE | cimetidine hydrochloride | INJECTABLE;INJECTION | 074344-001 | Jan 31, 1995 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
| Hospira Inc | IMIPENEM AND CILASTATIN | cilastatin sodium; imipenem | POWDER;INTRAVENOUS | 091007-001 | Nov 16, 2011 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
| Hospira | DIAZEPAM | diazepam | INJECTABLE;INJECTION | 071584-001 | Oct 13, 1987 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
| Hospira | KETOROLAC TROMETHAMINE | ketorolac tromethamine | INJECTABLE;INJECTION | 074802-002 | Jun 5, 1997 | AP | RX | No | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Hospira | KETOROLAC TROMETHAMINE | ketorolac tromethamine | INJECTABLE;INJECTION | 074801-001 | Jun 5, 1997 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Hospira
Paragraph IV (Patent) Challenges for HOSPIRA drugs
| Drugname | Dosage | Strength | Tradename | Submissiondate |
|---|---|---|---|---|
| ➤ Subscribe | Injection | 1 mg/mL, 50 mL vials | ➤ Subscribe | 2011-12-16 |
| ➤ Subscribe | Injection | 4 mcg/mL, 50 mL and 100 mL vials | ➤ Subscribe | 2013-12-26 |
| ➤ Subscribe | Injection | 100 mg/mL, 2.5 mL vials | ➤ Subscribe | 2007-09-24 |
| ➤ Subscribe | Injection | 100 mcg/mL | ➤ Subscribe | 2009-04-08 |
| ➤ Subscribe | Injection | 4 mcg/mL, 20 mL vials | ➤ Subscribe | 2015-09-30 |
International Patents for Hospira Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Japan | 5927680 | ⤷ Try a Trial |
| Guatemala | 201300055 | ⤷ Try a Trial |
| China | 107802624 | ⤷ Try a Trial |
| Malaysia | 161022 | ⤷ Try a Trial |
| European Patent Office | 4066849 | ⤷ Try a Trial |
| South Korea | 20140096238 | ⤷ Try a Trial |
| Ecuador | SP13012569 | ⤷ Try a Trial |
| >Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Hospira Drugs
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 0126587 | SPC/GB95/030 | United Kingdom | ⤷ Try a Trial | PRODUCT NAME: MEROPENEM OPTIONALLY IN THE FORM OF A HYDRATE AND /OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF; REGISTERED: IT 99/1994 19940817; UK 12619/0097 19950119; UK 12619/0098 19950119; UK 12619/0099 19950119; UK 12619/0100 19950119 |
| 0717738 | 02C0005 | France | ⤷ Try a Trial | PRODUCT NAME: LINEZOLIDE; NAT. REGISTRATION NO/DATE: NL 26 660 20010831; FIRST REGISTRATION: GB - PL 00 32/0261 20010105 |
| 2158901 | C 2018 012 | Romania | ⤷ Try a Trial | PRODUCT NAME: AZTREONAM LIZINA; NATIONAL AUTHORISATION NUMBER: EU/1/09/543/001; DATE OF NATIONAL AUTHORISATION: 20090921; NUMBER OF FIRST AUTHORISATION IN EUROPEAN ECONOMIC AREA (EEA): EU/1/09/543/001; DATE OF FIRST AUTHORISATION IN EEA: 20090921 |
| 1425001 | SPC/GB14/034 | United Kingdom | ⤷ Try a Trial | PRODUCT NAME: VILANTEROL OR SALTS OR SOLVATES THEREOF (I.E., 4-((1R)-2-((6-(2-((2,6-DICHLOROBENZYL)OXY)ETHOXY)HEXYL)AMINO)-1-HYDROXYETHYL)-2-(HYDROXYMETHYL)PHENOL OR SALTS OR SOLVATES THEREOF); REGISTERED: UK EU/1/13/886/001 20131114; UK EU/1/13/886/002 20131114; UK EU/1/13/886/003 20131114; UK EU/1/13/886/004 20131114; UK EU/1/13/886/005 20131114; UK EU/1/13/886/006 20131114 |
| 2673237 | 1990016-6 | Sweden | ⤷ Try a Trial | PRODUCT NAME: SODIUM ZIRCONIUM CYCLOSILICATE; REG. NO/DATE: EU/1/17/1173 20180326 |
| 1562603 | C 2014 025 | Romania | ⤷ Try a Trial | PRODUCT NAME: OLODATEROL, IZOMERI OPTICI INDIVIDUALI AI ACESTUIA,AMESTECURI DE ENANTIOMERI INDIVIDUALI SAU RACEMATI, SARURILE DE ADITIE ACIDA ALE ACESTORA CU ACIZI ACCEPTABILIFARMACOLOGIC, CA SI SOLVATI SI/SAU HIDRATI AI ACESTORA, IN SPECIAL OLODATEROL SI CLORHI DRAT DE OLODATEROL -6-HIDROXI-2-{[1-(4-METOXIFENIL)-1,1-DIMETILETIL]AMINO}ETIL]-2H-1,4-BENZOXAZIN-3(4H)-ONA(CACLORHIDRAT); NATIONAL AUTHORISATION NUMBER: 6414/2014/01, 6414/2014/02, 6414/2014/03, 6414/2014/04; DATE OF NATIONAL AUTHORISATION: 20140507; NUMBER OF FIRST AUTHORISATION IN EUROPEAN ECONOMIC AREA (EEA): MA211/00401; DATE OF FIRST AUTHORISATION IN EEA: 20130918 |
| 0933372 | SPC/GB08/018 | United Kingdom | ⤷ Try a Trial | PRODUCT NAME: FOSAMPRENAVIR CALCIUM: ((1S,2R)-3-(((4-AMINOPHENYL)SULFONYL)(2-METHYLPROPYL)AMINO)-1-(PHENYLMETHYL)-2(PHOSPHONOOXY)PROPYL)-CARBABAMIC ACID C-((3S)-TETRAHYDRO-3-FURANYL) ESTER CALCIUM SALT; REGISTERED: UK EU/1/04/282/001 20040712; UK EU/1/04/282/002 20040712 |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
